Exploring novel modulators for rescuing cigarette smoke-induced corneal edema and examining iPSC-derived corneal endothelial cells as a treatment modality
探索新型调节剂来挽救香烟烟雾引起的角膜水肿并检查 iPSC 衍生的角膜内皮细胞作为治疗方式
基本信息
- 批准号:10723408
- 负责人:
- 金额:$ 9.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-30 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdherent CultureAdvocateAffectAnimal ModelAttenuatedBlindnessCRISPR/Cas technologyCarbon MonoxideCell Culture TechniquesCell DensityCell LineCell TherapyCellsCigaretteClinicalComplex MixturesCorneaCorneal DiseasesCorneal EndotheliumCorneal edemaCritical PathwaysDataData SetDescemet&aposs membraneDiabetes MellitusDiseaseEarly treatmentEdemaEndothelial CellsEyeEyedropsGeneticGoalsGraft RejectionHumanHydration statusIn VitroIndividualInjection of therapeutic agentInjectionsKeratoplastyKnowledgeLeadMediatingMethodologyModalityMolecularMonkeysMorbidity - disease rateNQO1 geneNatural regenerationNicotineOryctolagus cuniculusOutcomeOxidative StressOxidative Stress InductionPathway interactionsPatientsPre-Clinical ModelProteomeReporterRepressionResearchSeveritiesSignal PathwaySignal TransductionSmoking HistorySourceStructural ProteinTechniquesTherapeuticTissue DonorsTissuesTopical applicationToxinTransplantation SurgeryTreatment EfficacyValidationanterior chambercigarette smokecigarette smoke-inducedeffective therapyefficacy evaluationendothelial dysfunctionexperimental studyexposure to cigarette smokefly ashhigh riskhuman embryonic stem cellin vivoinduced pluripotent stem cellinhibitorinsightminimally invasivenovelnovel therapeuticsoxidative damagepre-clinicalresponserestorationscreeningstem cells
项目摘要
Project Summary
Cigarette smoke (CS) is a complex mixture of toxins (e.g., nicotine, carbon monoxide) that
affects multiple tissues of the eye including the cornea, the outermost tissue of the eye. The
cornea is at high risk due to its proximity to the burning end of the cigarette and flying ash.
Corneal endothelium (CE) is the innermost layer of the cornea responsible for corneal hydration.
CS results in progressive corneal endothelial cell (CEC) loss leading to corneal edema and
vision loss if remains untreated. The severity of CS-induced corneal edema is further
compounded with preexisting morbidities such as corneal endothelial dystrophies and diabetes.
Our preliminary studies of proteome profiling have demonstrated that CS triggers CEC loss and
disruption of critical structural proteins in Descemet’s membrane (DM). We further identified
elevated levels of oxidative stress-associated indicators and decreased levels of CE-associated
markers in response to cigarette smoke extract (CSE) treatment in human induced pluripotent
stem cell (iPSC)-derived CEC monolayer cultures. In parallel, we have shown that human
embryonic stem cell (hESC)-derived CECs can form a functional CE on denuded DM (DM
without CE) in rabbits and monkeys. Moreover, we have also shown that injected hESC-derived
CECs can form a functional CE on denuded stroma (stroma without CE and DM).
In this application, we will build on these datasets through large-scale screening of cellular
pathway modulators to establish a non-invasive topical eye drop approach. In parallel, we will
demonstrate the efficacy of the iPSC-derived CECs injection technique as a minimally invasive,
donor tissue-independent, treatment modality. Taken together, the combined knowledge gained
from identifying modulators and cell therapy will make a paradigm by offering an unlimited
source for the treatment of oxidative stress-induced CE disorders.
项目概要
香烟烟雾 (CS) 是一种复杂的毒素混合物(例如尼古丁、一氧化碳),
影响眼睛的多个组织,包括角膜(眼睛最外层的组织)。
由于角膜靠近香烟的燃烧端和飞扬的灰烬,因此角膜面临很高的风险。
角膜内皮(CE)是角膜的最内层,负责角膜水合作用。
CS 导致进行性角膜内皮细胞 (CEC) 损失,导致角膜水肿和
如果不治疗,视力会下降,CS 引起的角膜水肿会更加严重。
与先前存在的疾病(例如角膜内皮营养不良和糖尿病)混合在一起。
我们对蛋白质组分析的初步研究表明,CS 会引发 CEC 损失并
我们进一步确定了后弹力层 (DM) 中关键结构蛋白的破坏。
氧化应激相关指标水平升高,CE相关指标水平降低
人类诱导多能性中香烟烟雾提取物(CSE)治疗反应的标志物
与此同时,我们已经证明人类干细胞 (iPSC) 衍生的 CEC 单层培养物。
胚胎干细胞 (hESC) 衍生的 CEC 可以在裸露的 DM 上形成功能性 CE (DM
此外,我们还证明注射 hESC 衍生的药物。
CEC可以在裸露的基质(没有CE和DM的基质)上形成功能性CE。
在此应用程序中,我们将通过大规模筛选细胞来构建这些数据集
同时,我们将建立一种非侵入性局部滴眼剂的途径调节剂方法。
证明 iPSC 衍生的 CEC 注射技术作为微创、
综合起来,获得了与供体组织无关的治疗方式。
通过识别调节剂和细胞疗法将通过提供无限的
治疗氧化应激引起的 CE 疾病的来源。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Muhammad Ali Riaz其他文献
Muhammad Ali Riaz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
A HUMAN IPSC-BASED ORGANOID PLATFORM FOR STUDYING MATERNAL HYPERGLYCEMIA-INDUCED CONGENITAL HEART DEFECTS
基于人体 IPSC 的类器官平台,用于研究母亲高血糖引起的先天性心脏缺陷
- 批准号:
10752276 - 财政年份:2024
- 资助金额:
$ 9.02万 - 项目类别:
Investigating the Ability of Human Blood Neutrophils to Kill Cancer
研究人类血液中性粒细胞杀死癌症的能力
- 批准号:
10648774 - 财政年份:2023
- 资助金额:
$ 9.02万 - 项目类别:
Regulation of Adherent Cell Proliferation by Matrix Viscoelasticity
基质粘弹性对贴壁细胞增殖的调节
- 批准号:
10735701 - 财政年份:2023
- 资助金额:
$ 9.02万 - 项目类别:
Parallel Characterization of Genetic Variants in Chemotherapy-Induced Cardiotoxicity Using iPSCs
使用 iPSC 并行表征化疗引起的心脏毒性中的遗传变异
- 批准号:
10663613 - 财政年份:2023
- 资助金额:
$ 9.02万 - 项目类别: